Observations placeholder
Horizant
Identifier
019106
Type of Spiritual Experience
Background
A description of the experience
Gabapentin enacarbil (Horizant (in USA), , formerly known as XP-13512) is a prodrug for the anticonvulsant and analgesic drug gabapentin. It was designed for increased oral bioavailability over gabapentin and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability especially when taken with a fatty meal. Gabapentin enacarbil passed human clinical trials for the treatment of restless legs syndrome.
Gabapentin enacarbil was denied approval by the U.S. Food and Drug Administration (FDA) in February 2010, citing concerns about possible increased cancer risk shown by some animal studies. Similar concerns had been raised about gabapentin itself in the past, but were felt to be outweighed by its clinical utility as an anticonvulsant, whereas the treatment of restless legs syndrome was not seen to justify the same kind of risk.
On Dec, 10, 2016 383 people reported to have side effects when taking Horizant.
Among them, 10 people (2.61%) have Hallucination
Time on Horizant when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |